Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
暂无分享,去创建一个
Axel Benner | Peter Lichter | Dirk Winkler | Sebastian Hafner | Hartmut Döhner | Stephan Stilgenbauer | R. Schlenk | H. Döhner | P. Lichter | M. Bangerter | S. Stilgenbauer | A. Benner | D. Winkler | A. Bühler | A. Kröber | Richard F Schlenk | Alexander Kröber | Till Seiler | D. Kienle | T. Seiler | Johannes Bloehdorn | Andreas Bühler | Dirk Kienle | Markus Bangerter | J. Bloehdorn | S. Hafner
[1] E. Cronkite,et al. Clinical staging of chronic lymphocytic leukemia. , 1975, Blood.
[2] A. Weiss,et al. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. , 1994, Science.
[3] Steven L. Allen,et al. Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia , 2004, The Journal of experimental medicine.
[4] L. Rassenti,et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. , 1998, The Journal of clinical investigation.
[5] H. Döhner,et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. , 2005, Blood.
[6] D. Oscier,et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. , 2002, Blood.
[7] Mark J. Thomas,et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis , 1981, Cancer.
[8] Steven L. Allen,et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.
[9] Göran Roos,et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. , 2002, Blood.
[10] Adrian Wiestner,et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia , 2004, The Lancet.
[11] Arthur Weiss,et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. , 2004, The New England journal of medicine.
[12] T. Hope,et al. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. , 1994, Science.
[13] Adrian Wiestner,et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. , 2003, Blood.
[14] L. Klein-Hitpass,et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia , 2005, Leukemia.
[15] Emili Montserrat,et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. , 2003, The New England journal of medicine.
[16] N. Chiorazzi,et al. mechanisms of disease Chronic Lymphocytic Leukemia , 2010 .
[17] J. Byrd,et al. Chronic lymphocytic leukemia. , 2010, Hematology. American Society of Hematology. Education Program.
[18] T J Hamblin,et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.
[19] G. Juliusson,et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. , 2003, Blood.
[20] H. Döhner,et al. Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes. , 2006, Blood.
[21] L. Rassenti,et al. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. , 2005, Blood.
[22] Arthur Weiss,et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. , 2002, Blood.
[23] E. Montserrat,et al. Chronic lymphocytic leukemia. , 1995, The New England journal of medicine.
[24] A Benner,et al. Genomic aberrations and survival in chronic lymphocytic leukemia. , 2000, The New England journal of medicine.
[25] David Botstein,et al. Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.
[26] Axel Benner,et al. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. , 2002, Blood.
[27] L. Kanz,et al. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer. , 1998, Seminars in oncology.
[28] E. Korn. Censoring distributions as a measure of follow-up in survival analysis. , 1986, Statistics in medicine.
[29] Anna Tramontano,et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. , 2004, The Journal of clinical investigation.
[30] Sunil J Rao,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .
[31] D. Cox. Regression Models and Life-Tables , 1972 .
[32] J. Orchard,et al. Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire. , 2003, Blood.
[33] Y. Tu,et al. Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells , 2001, The Journal of experimental medicine.
[34] Frank E. Harrell,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .
[35] T. Möröy,et al. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia , 2003, Leukemia.